TARGET GROUP INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.00495 USD | -16.10% |
|
+66.67% | +177.78% |
| 05-08 | Target Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 03-20 | Target Group Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2022 | - | Sales 2023 | 3.72M 293M | Capitalization | 1.14M 89.36M |
|---|---|---|---|---|---|
| Net income 2022 | -4M -315M | Net income 2023 | - 0 | EV / Sales 2022 | - |
| Net Debt 2022 | 10.9M 858M | Net Debt 2023 | 6.98M 549M | EV / Sales 2023 | 2.18 x |
| P/E ratio 2022 |
-0.55
x | P/E ratio 2023 |
-3.51
x | Employees | 49 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 89.94% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -16.10% | ||
| 1 week | +66.67% | ||
| Current month | -35.06% | ||
| 1 month | -23.08% | ||
| 3 months | +56.25% | ||
| 6 months | +108.33% | ||
| Current year | +177.78% |
1 week
0.00
0.01
1 month
0.000.01
Current year
0.000.01
1 year
0.000.02
3 years
0.000.03
5 years
0.000.13
10 years
0.001 250.00
| Managers | Title | Age | Since |
|---|---|---|---|
Anthony Zarcone
CEO | Chief Executive Officer | 50 | 22/10/19 |
| Director/Board Member | 64 | 19/12/19 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Saul Niddam
BRD | Director/Board Member | 67 | 22/10/19 |
Anthony Zarcone
CEO | Chief Executive Officer | 50 | 22/10/19 |
| Director/Board Member | 64 | 19/12/19 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/05/24 | 0.00495 | -16.10% | 1 777 |
| 16/05/24 | 0.0059 | +3.51% | 500,100 |
| 15/05/24 | 0.0057 | +5.56% | 17,000 |
| 13/05/24 | 0.0054 | +80.00% | 100 |
| 10/05/24 | 0.003 | 0.00% | 40,500 |
Delayed Quote OTC Markets, May 17, 2024 at 02:37 pm
More quotes
Target Group Inc. is a cannabis and hemp consumer packaged goods (CPG) company. The Company is engaged in the cultivation, processing, and distribution of curated cannabis products for the adult-use medical and recreational cannabis market in Canada and in the United States. Its products include Cannabis flower pods for vaporizer use, Cannabis extract pods for vaporizer use, Cannabis pre-rolls, K-Cup infused coffee and tea pots, Infused cannabis beverages, Infused cannabis edibles and infused topical products and CBD wellness products. The Company's subsidiary, Canary Rx Inc, is a Canadian licensed producer, which operates an approximately 44,000 square foot facility located in Norfolk County, Ontario. The Company's subsidiary, CannaKorp Inc., has developed a single-use pre-measured pod and vaporizer system, such as The Wisp and Wisp Pods for consumers interested in vaporizing natural herbs, including cannabis.
| 1st Jan change | Capi. | |
|---|---|---|
| +177.78% | 3.64M | |
| -.--% | 339M | |
| -37.75% | 335M | |
| +52.26% | 316M | |
| +35.05% | 291M | |
| +57.56% | 210M | |
| +52.17% | 142M | |
| +140.77% | 137M | |
| +34.62% | 128M | |
| -28.57% | 121M |
- Stock Market
- Equities
- CHZP Stock
